Inflammation and Survival in Bladder Cancer
Author Information
Author(s): Hilmy M, Bartlett J M S, Underwood M A, McMillan D C
Primary Institution: University Department of Surgery, Royal Infirmary, Glasgow
Hypothesis
The study aims to examine the relationship between stage, grade, C-reactive protein, and cancer-specific survival in patients with bladder cancer.
Conclusion
Both tumor grade and the presence of a systemic inflammatory response are independent predictors of cancer-specific survival in patients with bladder cancer.
Supporting Evidence
- Elevated C-reactive protein levels were associated with poorer survival outcomes.
- Multivariate analysis showed that stage and grade were significant predictors of survival.
- Patients with elevated preoperative C-reactive protein had a mean cancer-specific survival of 65.5 months.
Takeaway
This study found that inflammation in the body can affect how long people with bladder cancer live, and that certain cancer characteristics are important for predicting survival.
Methodology
Patients with biopsy-proven transitional cell carcinoma were reviewed, and their C-reactive protein levels were measured before and after surgery to assess survival outcomes.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the single-center design.
Limitations
The study is limited to a single urological unit and may not be generalizable to all bladder cancer patients.
Participant Demographics
The majority of participants were male (71%) and over the age of 65 (65%).
Statistical Information
P-Value
P=0.008
Confidence Interval
95% CI 1.37–8.29
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website